{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:56:55Z","timestamp":1782917815324,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clcc.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T11:27:36Z","timestamp":1738582056000},"page":"256-263.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Values of Pre- and Post-Therapeutic FDG-PET in Anal Canal Cancer: Analysis of a Prospective Study"],"prefix":"10.1016","volume":"24","author":[{"given":"C.","family":"Zwarthoed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6211-6977","authenticated-orcid":false,"given":"C.","family":"Jaraudias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Evesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mitrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ch\u00e2teau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bailleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2025.01.006_bib0001","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2025.01.006_bib0002","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2025.01.006_bib0003","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","article-title":"Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Rao","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2025.01.006_bib0004","unstructured":"Moureau-Zabotto L, Vendrely V, Abramowitz L, et al.. \u00ab\u202fCancer du canal anal\u202f\u00bb. Th\u00e9saurus National de Canc\u00e9rologie Digestive. 2023. decemberen ligne. https:\/\/www.onco-hdf.fr\/app\/uploads\/2023\/08\/tncd_chap-06_cancer-canal-anal_2022-10-17.pdf. Accessed October 17, 2022."},{"key":"10.1016\/j.clcc.2025.01.006_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11307-005-0003-6","article-title":"Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal","volume":"7","author":"Trautmann","year":"2005","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.clcc.2025.01.006_bib0006","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2008.04.003","article-title":"Assessing the impact of FDG-PET in the management of anal cancer","volume":"87","author":"Nguyen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2025.01.006_bib0007","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2009.04.020","article-title":"Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer","volume":"77","author":"Mistrangelo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2025.01.006_bib0008","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00259-016-3475-5","article-title":"Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET\/CT in anal canal cancer","volume":"44","author":"Gauth\u00e9","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.clcc.2025.01.006_bib0009","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3390\/cancers12061512","article-title":"Prognostic impact of pretherapeutic FDG-PET in localized anal cancer","volume":"12","author":"Le Thiec","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clcc.2025.01.006_bib0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2007.09.005","article-title":"Tumor response and survival predicted by post-therapy FDG-PET\/CT in anal cancer","volume":"71","author":"Schwarz","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2025.01.006_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2019.03.014","article-title":"Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma","volume":"136","author":"Duimering","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2025.01.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109905","article-title":"Prognostic impact of post-treatment FDG PET\/CT in anal canal cancer: a prospective study","volume":"188","author":"Bailleux","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2025.01.006_bib0013","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.clcc.2025.01.006_bib0014","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clcc.2025.01.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246535","article-title":"Use of advanced PET-volume metrics predicts risk of local recurrence and overall survival in anal cancer","volume":"16","author":"Susko","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.clcc.2025.01.006_bib0016","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/1754-9485.13566","article-title":"Pre- and post-treatment FDG PET-CT as a predictor of patient outcomes in anal squamous cell carcinoma: A systematic review and meta-analysis","volume":"67","author":"Mac Curtain","year":"2023","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.clcc.2025.01.006_bib0017","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2010.02.019","article-title":"Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis","volume":"95","author":"Kidd","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2025.01.006_bib0018","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.adro.2017.04.007","article-title":"Quantitative FDG-PET\/CT predicts local recurrence and survival for squamous cell carcinoma of the anus","volume":"2","author":"Cardenas","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"1080","key":"10.1016\/j.clcc.2025.01.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170370","article-title":"PET imaging in anal canal cancer: a systematic review and meta-analysis","volume":"90","author":"Mahmud","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clcc.2025.01.006_bib0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.01.009","article-title":"FDG-PET\/CT in the evaluation of anal carcinoma","volume":"65","author":"Cotter","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2025.01.006_bib0021","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2967\/jnumed.107.042093","article-title":"Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis","volume":"48","author":"Lin","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clcc.2025.01.006_bib0022","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1182\/blood-2010-12-327767","article-title":"SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma","volume":"118","author":"Casasnovas","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clcc.2025.01.006_bib0023","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2967\/jnumed.124.267626","article-title":"Prognostic value of 18F-FDG PET\/CT assessment after radiotherapy of squamous cell carcinoma of the anus in patients from the National multicentric cohort FFCD-ANABASE","volume":"65","author":"Combet-Curt","year":"2024","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.clcc.2025.01.006_bib0024","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.3390\/ijms25074005","article-title":"Assessing circulating tumour DNA (ctDNA) as a biomarker for anal cancer management: A systematic review","volume":"25","author":"Temperley","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002825000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002825000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:20:10Z","timestamp":1769044810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002825000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1533002825000179"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2025.01.006","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Values of Pre- and Post-Therapeutic FDG-PET in Anal Canal Cancer: Analysis of a Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}